mTORC1 induces eukaryotic translation initiation factor 4E interaction with TOS-S6 kinase 1 and its activation

References

• Xu T, Zong Y, Peng L, et al. Overexpression of eIF4E in colorectal cancer patients is associated with liver metastasis. Onco Targets Ther. 2016;9:815–822.
   PubMed Web of Science ®Google Scholar
• Heikkinen T, Korpela T, Fagerholm R, et al. Eukaryotic translation initiation factor 4E (eIF4E) expression is associated with breast cancer tumor phenotype and predicts survival after anthracycline chemotherapy treatment. Breast Cancer Res Treat. 2013;141(1):79–88.
   PubMed Web of Science ®Google Scholar
• Liang S, Guo R, Zhang Z, et al. Upregulation of the eIF4E signaling pathway contributes to the progression of gastric cancer, and targeting eIF4E by perifosine inhibits cell growth. Oncol Rep. 2013;29(6):2422–2430.
   PubMed Web of Science ®Google Scholar
• Graff JR, Konicek BW, Lynch RL, et al. eIF4E activation is commonly Elevated in advanced human prostate cancers and significantly related to reduced patient survival. Cancer Res. 2009;69(9):3866–3873. .
   PubMed Web of Science ®Google Scholar
• Siddiqui N, Sonenberg N.. Signalling to eIF4E in cancer. Biochem Soc Trans. 2015;43:763–72.
   PubMed Web of Science ®Google Scholar
• Piserà A, Campo A, Campo S. Structure and functions of the translation initiation factor eIF4E and its role in cancer development and treatment. Journal of Genetics and Genomics. 2018;45(1):13–24.
   PubMed Web of Science ®Google Scholar
• Borden KLB The eukaryotic translation initiation factor eIF4E wears a “cap” for many occasions. Translation [Internet] 2016. Available from: https://www.tandfonline.com/doi/full/10.1080/21690731.2016.1220899
   Google Scholar
• Furic L, Rong L, Larsson O, et al. EIF4E phosphorylation promotes tumorigenesis and is associated with prostate cancer progression. Proc Natl Acad Sci U S A. 2010;107(32):14134–14139. .
   PubMed Web of Science ®Google Scholar
• Robichaud N, Del Rincon SV, Huor B, et al. Phosphorylation of eIF4E promotes EMT and metastasis via translational control of SNAIL and MMP-3. Oncogene. 2015;34(16):2032–2042. .
   PubMed Web of Science ®Google Scholar
• Robichaud N, Hsu BE, Istomine R, et al. Translational control in the tumor microenvironment promotes lung metastasis: phosphorylation of eIF4E in neutrophils. Proc Natl Acad Sci [Internet]. 2018;115(10):E2202–9. .
   PubMed Web of Science ®Google Scholar
• Majeed ST, Majeed R, Shah G, et al. S6 Kinase: a Compelling Prospect for Therapeutic Interventions [Internet]. In: Castanho FL, Garnes SDA, editors. Homeostasis-An Integrated Vision. Intech; 2019. p. 143–162. https://www.intechopen.com/books/homeostasis-an-integrated-vision/s6-kinase-a-compelling-prospect-for-therapeutic-interventions
   Google Scholar
• Karlsson E, Magić I, Bostner J, et al. Revealing Different Roles of the mTOR-Targets S6K1 and S6K2 in Breast Cancer by Expression Profiling and Structural Analysis. PLoS One. 2015;10(12):10.
   Web of Science ®Google Scholar
• Jafari N, Zheng Q, Li L, et al. p70S6K1 (S6K1)-mediated Phosphorylation Regulates Phosphatidylinositol 4-Phosphate 5-Kinase Type I γ Degradation and Cell Invasion. J Biol Chem. 2016;291(49):25729–25741.
   PubMed Web of Science ®Google Scholar
• Shveygert M, Kaiser C, Bradrick SS, et al. Regulation of Eukaryotic Initiation Factor 4E (eIF4E) Phosphorylation by Mitogen-Activated Protein Kinase Occurs through Modulation of Mnk1-eIF4G Interaction. Molecular and Cellular Biology. 2010;30(21):5160–5167. http://mcb.asm.org/cgi/doi/10.1128/MCB.00448–10
   PubMed Web of Science ®Google Scholar
• Proud CG. Mnks, eIF4E phosphorylation and cancer. Biochimica Et Biophysica Acta (BBA) - Gene Regulatory Mechanisms. 2015;1849(7):766–773.
   PubMed Web of Science ®Google Scholar
• Batool A, Majeed ST, Aashaq S, et al. Eukaryotic initiation factor 4E is a novel effector of mTORC1 signaling pathway in cross talk with Mnk1. Mol Cell Biochem. 2020;465(1–2):13–26.
   PubMed Web of Science ®Google Scholar
• Batool A, Majeed ST, Aashaq S, et al. Eukaryotic Initiation Factor 4E (eIF4E) sequestration mediates 4E-BP1 response to rapamycin. Int J Biol Macromol [Internet]. 2019;125:651–659.
   PubMed Web of Science ®Google Scholar
• Beigh MA, Showkat M, Hussain MU, et al. Loss of hydrophobic motif and activation loop phosphorylation is a consequence and not the mechanism of S6 kinase 1 inhibition by rapamycin. J Biol Regul Homeost Agents. 2013;27(2):399–408.
   PubMed Web of Science ®Google Scholar
• Kim D-H, Sarbassov DD, Ali SM, et al. mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. Cell. 2002;110(2):163–175.
   PubMed Web of Science ®Google Scholar
• Beigh MA, Showkat M, Ul Hussain M, et al. Rapamycin inhibition of baculovirus recombinant (BVr) ribosomal protein S6 kinase (S6K1) is mediated by an event other than phosphorylation. Cell Commun Signal. 2012;10:10.
   PubMed Web of Science ®Google Scholar
• Zhang S, Hu B, Lv X, et al. The prognostic role of ribosomal protein S6 kinase 1 pathway in patients with solid tumors: a meta-analysis. Front Oncol. 2019;9.
   PubMedGoogle Scholar
• Li PD, Zhang WJ, Zhang MY, et al. Overexpression of RPS6KB1 predicts worse prognosis in primary HCC patients. Med Oncol. 2012;29(5):3070–3076.
   PubMed Web of Science ®Google Scholar
• Martin ME, Pérez MI, Redondo C, et al. 4E binding protein 1 expression is inversely correlated to the progression of gastrointestinal cancers. Int J Biochem Cell Biol. 2000;32(6):633–642.
   PubMed Web of Science ®Google Scholar
• Jossé L, Xie J, Proud CG, et al. mTORC1 signalling and eIF4E/4E-BP1 translation initiation factor stoichiometry influence recombinant protein productivity from GS-CHOK1 cells. Biochem J. 2016;473(24):4651–4664.
   PubMedGoogle Scholar
• Alain T, Morita M, Fonseca BD, et al. eIF4E/4E-BP ratio predicts the efficacy of mTOR targeted therapies. Cancer Res. 2012;72(24):6468–6476.
   PubMed Web of Science ®Google Scholar
• Batool A, Majeed ST, Aashaq S, et al. Eukaryotic Initiation Factor 4E phosphorylation acts a switch for its binding to 4E-BP1 and mRNA cap assembly. Biochem Biophys Res Commun. 2020. DOI:10.1016/j.bbrc.2020.04.086
   PubMed Web of Science ®Google Scholar
• Yang H, Jiang X, Li B, et al. Mechanisms of mTORC1 activation by RHEB and inhibition by PRAS40. Nature. 2017;552(7685):368–373.
   PubMed Web of Science ®Google Scholar
• Showkat M, Beigh MA, Bhat BB, et al. Phosphorylation dynamics of eukaryotic initiation factor 4E binding protein 1 (4E-BP1) is discordant with its potential to interact with eukaryotic initiation factor 4E (eIF4E). Cell Signal. 2014;26(10):2117–2121.
   PubMed Web of Science ®Google Scholar
• Wendel H-G, Silva RLA, Malina A, et al. Dissecting eIF4E action in tumorigenesis. Genes Dev. 2007;21(24):3232–3237. .
   PubMed Web of Science ®Google Scholar
• Dennis PB. Mammalian TOR: a homeostatic ATP sensor. Science. 2001;294(5544):1102–1105.
   PubMed Web of Science ®Google Scholar
• Kurcinski M, Jamroz M, Blaszczyk M, et al. CABS-dock web server for the flexible docking of peptides to proteins without prior knowledge of the binding site. Nucleic Acids Res. 2015;43(W1):W419–24.
   PubMed Web of Science ®Google Scholar
• Brown MC, Gromeier M. MNK Controls mTORC1:Substrate Association through Regulation of TELO2 Binding with mTORC1. Cell Rep. 2017;18(6):1444–1457.
   PubMed Web of Science ®Google Scholar
• Stead RL, Proud CG. Rapamycin enhances eIF4E phosphorylation by activating MAP kinase-interacting kinase 2a (Mnk2a). FEBS Lett. 2013;587(16):2623–2628.
   PubMed Web of Science ®Google Scholar
• Schalm SS, Blenis J. Identification of a conserved motif required for mTOR signaling. Curr Biol. 2002;12(8):632–639.
   PubMed Web of Science ®Google Scholar
• Nojima H, Tokunaga C, Eguchi S, et al. The mTOR partner, Raptor binds the mTOR substrates, p70 S6 kinase and 4E-BP1 through their TOS (TOR signaling) motif. J Biol Chem. 2003. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12604610
   Web of Science ®Google Scholar
• Ali SM, Sabatini DM. Structure of S6 kinase 1 determines whether raptor-mTOR or rictor-mTOR phosphorylates its hydrophobic motif site. J Biol Chem. 2005;280(20):19445–19448.
   PubMed Web of Science ®Google Scholar
• Carroll M, Borden KLB The Oncogene eIF4E: using Biochemical Insights to Target Cancer. Journal of Interferon & Cytokine Research. 2013;33(5):227–238. http://online.liebertpub.com/doi/abs/10.1089/jir.2012.0142
   PubMed Web of Science ®Google Scholar
• Carter JH, Deddens JA, Spaulding IV NR, et al. Phosphorylation of eIF4E serine 209 is associated with tumour progression and reduced survival in malignant melanoma. Br J Cancer. 2016;114(4):444–453. .
   PubMed Web of Science ®Google Scholar
• Silvera D, Formenti SC, Schneider RJ. Translational control in cancer. Nature Reviews Cancer. 2010;10(4):254–266.
   PubMed Web of Science ®Google Scholar
• Armengol G, Rojo F, Castellví J, et al. 4E-binding protein 1: a key molecular “funnel factor” in human cancer with clinical implications. Cancer Res. 2007;67(16):7551–7555.
   PubMed Web of Science ®Google Scholar
• Kim YY, Von Weymarn L, Larsson O, et al. Eukaryotic initiation factor 4E binding protein family of proteins: sentinels at a translational control checkpoint in lung tumor defense. Cancer Res. 2009;69(21):8455–8462.
   PubMed Web of Science ®Google Scholar
• Müller D, Lasfargues C, El Khawand S, et al. 4E-BP restrains eIF4E phosphorylation. Translation [Internet] 2013. Available from: http://www.tandfonline.com/doi/abs/10.4161/trla.25819
   Google Scholar